Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 462,895 | 71,353 | 36,709 | 25,131 | 8,345 |
| Marketable Securities | N/A | N/A | N/A | 23,608 | N/A |
| Receivables | 2,125 | 2,179 | 4,481 | 480 | 3,633 |
| Other current assets | 0 | 0 | 0 | 590 | 0 |
| TOTAL | $467,789 | $74,290 | $41,828 | $50,868 | $12,331 |
| Non-Current Assets | |||||
| PPE Net | 3,378 | 2,349 | 1,975 | 1,049 | 1,335 |
| Investments And Advances | 0 | 263 | 288 | 0 | 0 |
| Other Non-Current Assets | 5,289 | 5,241 | 107 | 107 | 70 |
| TOTAL | $8,667 | $7,853 | $2,370 | $1,156 | $1,405 |
| Total Assets | $476,456 | $82,143 | $44,198 | $52,024 | $13,736 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,250 | N/A | N/A | N/A | 133 |
| Accounts payable and accrued liabilities | 10,774 | 5,793 | 2,398 | 1,790 | 3,357 |
| Accrued Expenses | 19,389 | 7,134 | 3,907 | 2,793 | 1,061 |
| TOTAL | $49,521 | $21,324 | $12,577 | $11,040 | $8,734 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,845 | 14,995 | 9,911 | N/A | N/A |
| Deferred Revenues | 18,108 | 8,397 | 6,272 | 6,457 | 4,183 |
| Other Non-Current Liabilities | 4,025 | 4,850 | 0 | 0 | 15 |
| TOTAL | $30,382 | $35,027 | $17,979 | $7,190 | $3,425 |
| Total Liabilities | $79,903 | $56,351 | $30,556 | $18,230 | $12,159 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | N/A | 3,936 |
| Common Shares | 26 | 15 | 214 | 212 | N/A |
| Retained earnings | -143,816 | -71,668 | -44,874 | -23,089 | -12,187 |
| Other shareholders' equity | 0 | 0 | 0 | -3 | 0 |
| TOTAL | $396,553 | $25,792 | $13,642 | $33,794 | $1,577 |
| Total Liabilities And Equity | $476,456 | $82,143 | $44,198 | $52,024 | $13,736 |